The Boettcher Foundation Board of Trustees has released the names of the three early-career scientists selected for the third class of Boettcher Investigators in the Webb-Waring Biomedical Research Program.
Timothy W. Schultz, President and Executive Director of the Boettcher Foundation, said "Through this program, the Boettcher Foundation has been able to bring resources to an area where funds are currently lacking and where federal and private research programs provide limited support. Early-career investigators quite frequently have a difficult time securing a first opportunity at an independent research effort that will move them out of the laboratory of their mentors and onto their own new and exciting areas of discovery."
The 2012 (third) Class of Boettcher Investigators in the Webb-Waring Biomedical Research Program includes:
* Harald Junge, Ph.D. , University of Colorado at Boulder, Retinal Vascular Development and Disease
* Matthew Kennedy, Ph.D., University of Colorado – Anschutz Medical Campus, Molecular Mechanisms of Alzheimer's Pathology
* Chad G. Pearson, Ph.D., University of Colorado – Anschutz Medical Campus, Organization of the Microtubule Cytoskeleton for Cell Division and Signaling
With the addition of the 2012 Class, there are now fourteen Boettcher Investigators conducting research in the following Colorado institutions: University of Colorado Anschutz Medical Campus, University of Colorado Boulder, Colorado State University, National Jewish Health and Colorado School of Mines.
Link to the Business Wire release
Link to the PitchEngine Social Media Release